Latest news
25-04-2022 - JDRF Request for Applications: Adjunctive Therapies for Glucometabolic Control in Type 1 Diabetes
Funding of up to $2,000,000 is available for clinical trials and mechanistic clinical studies to support the development of adjunctive therapies to improve glucose and metabolic outcomes in people with type 1 diabetes (T1D).
The Juvenile Diabetes Research Foundation (JDRF) has issued a Request for Applications - Clinical Trials and Mechanistic Clinical Studies to Advance Adjunctive Therapies for Glucometabolic Control in Type 1 Diabetes (T1D) - to seek proposals for clinical trials to evaluate glucometabolic therapies in people with T1D or mechanistic clinical studies to advance knowledge of glucometabolic control in T1D toward the goal of future therapy development.
[...]